Serological correlate of protection against norovirus-induced gastroenteritis
about
Norovirus immunity and the great escapeImmunogenetic mechanisms driving norovirus GII.4 antigenic variationNorovirusVaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio choleraeStructural basis of glycan interaction in gastroenteric viral pathogensNorovirus immunology: Of mice and mechanismsSeroepidemiology of norovirus-associated travelers' diarrheaIntranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccineNorovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens.Antiviral targets of human norovirusesEmergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunityHuman Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.Vaccine against norovirus.B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.The state of norovirus vaccines.Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder.Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.Within-host evolution results in antigenically distinct GII.4 norovirusesNewly isolated mAbs broaden the neutralizing epitope in murine norovirus.Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.Branched-linear and agglomerate protein polymers as vaccine platforms.TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccinesEpidemiology of human noroviruses and updates on vaccine developmentNorovirus GII.4 strain antigenic variationReplication of human noroviruses in stem cell-derived human enteroids.Norovirus P particle efficiently elicits innate, humoral and cellular immunityIdentification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid.Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in miceIsolation of cross-reactive human monoclonal antibodies that prevent binding of human noroviruses to histo-blood group antigens.Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activityIntranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine.Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassayCharacterization of emerging GII.g/GII.12 noroviruses from a gastroenteritis outbreak in the United States in 2010Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trialAntigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge SeraGenotype considerations for virus-like particle-based bivalent norovirus vaccine composition.Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.
P2860
Q21090486-FACCB21C-30A7-468D-A844-C7273288EF3DQ24810360-C6DBC4FC-A397-42B9-AAA9-7DA4B3FD6FAAQ26864280-5823C580-7B3C-40D8-A2C8-A5587C77B51DQ27004488-0D73A804-BED4-4FDC-929F-306136B7187DQ27030776-3D304DFF-8371-4549-AE3C-8F1B58B69674Q28083087-EA67DF98-73AE-4A2F-9FE3-B4D1AAB34624Q28395024-296AF302-46F4-4910-A0EB-9DD261797967Q28728786-5FDA2146-3C89-45C9-A91B-A4B5C94B4F6AQ30248992-EB40D54C-BC0E-459D-BC2C-73E814DB8FC9Q30249527-603BA347-CF3B-4DC6-BFF9-BC5970E0A902Q30352529-465B55DE-FA47-4258-8025-087745E01F23Q30401642-B1492634-26AA-4FC4-9F32-94FE253EFFB6Q30409563-A543FBCB-634E-4815-8861-3AEC1D945DACQ30425145-0BF71B73-1E80-4278-9AF9-C082271B4FF8Q33578075-1FBD6C53-37B2-4067-8D59-6A9EA7BB053FQ33654573-88330784-80C4-48EF-96CC-88FC30B24D42Q33678125-3955ECAB-7FF5-4980-8504-D3B43952A0F9Q33703664-C8DB590E-BA53-46EA-BDD0-48E23C8BDB84Q33743992-B1B125F7-35B5-4981-8E1B-DD09DB70FF7EQ33744124-224EE44B-84EC-4F6D-8F1F-BBD0A9DF9A7FQ34054294-57595158-DD3F-476B-8C41-352D948E614BQ34059136-C535A938-3BE2-4B0B-AA61-A62C44772F43Q34059409-BE2732CE-1899-4D68-91C2-9FBD065722B5Q34064413-8E0A0D25-D092-4DC8-A3A4-27813A9A5DADQ34290717-F5AED656-1E2D-472B-BF69-566CC852F0FAQ34385139-D38F731A-128A-473F-A4ED-8A94C7D5FC34Q34457831-DB180773-B0DA-4864-8B7A-6B832128B0F3Q34538562-D315275D-39AE-483E-802A-E7453EA6A3BDQ34702360-56C695A2-A452-4A6E-A902-176CD82044A8Q34785721-7A55CB65-3375-41D7-8788-598A21893559Q34907018-594977D1-D7F6-4EA1-B90A-0D08CBA6A0A7Q34985473-2366DE19-B9D2-4D45-B563-197793625927Q35021149-2F6603D0-9CAE-462C-A86A-0BD7753F9AB1Q35112676-22501342-9382-4079-AFD4-65621261E6BCQ35138622-D41628D2-4763-480E-95BF-A9E08DF9BCB5Q35192204-68C1819A-111F-4278-A19D-580CA38A182CQ35212408-B559460C-45F0-4358-AF52-7112519C0F8FQ35615462-56538A69-03F1-4510-83F5-775811D85B3FQ35656636-A54EC63E-8CEE-49B0-889D-A98FBE52CE3DQ35665784-2470189E-63C4-4D51-9E8E-1DCBFE0E2F76
P2860
Serological correlate of protection against norovirus-induced gastroenteritis
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Serological correlate of protection against norovirus-induced gastroenteritis
@ast
Serological correlate of protection against norovirus-induced gastroenteritis
@en
Serological correlate of protection against norovirus-induced gastroenteritis
@nl
type
label
Serological correlate of protection against norovirus-induced gastroenteritis
@ast
Serological correlate of protection against norovirus-induced gastroenteritis
@en
Serological correlate of protection against norovirus-induced gastroenteritis
@nl
prefLabel
Serological correlate of protection against norovirus-induced gastroenteritis
@ast
Serological correlate of protection against norovirus-induced gastroenteritis
@en
Serological correlate of protection against norovirus-induced gastroenteritis
@nl
P2093
P2860
P50
P356
P1476
Serological correlate of protection against norovirus-induced gastroenteritis
@en
P2093
Amanda Reeck
Antone R Opekun
Mark A Gilger
Owen Kavanagh
P2860
P304
P356
10.1086/656364
P407
P577
2010-10-01T00:00:00Z